<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8895544" created="25/08/2006" creator="Yo Shidahara"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>8895544</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="interferon" sem="Protein_family_or_group">Interferons</term> induce normal and aberrant <term id="T2" lex="retinoic-acid_receptors_type_alpha" sem="Protein_family_or_group"><term id="A1" sem="Carbohydrate">retinoic-acid</term> receptors type alpha</term> in <term id="T3" lex="acute_promyelocytic_leukemia_cell" sem="Cell_natural">acute promyelocytic leukemia cells</term>: potentiation of the induction of <term id="T4" lex="retinoid-dependent_differentiation_marker" sem="Protein_family_or_group"><term id="T5" lex="retinoid" sem="Organic_compound_other">retinoid</term>-dependent <term id="T6" lex="differentiation_marker" sem="Other">differentiation</term> markers</term>.</sentence>
<event id="E1">
<type class="Positive_regulation"/>
<theme idref="T2"/>
<cause idref="T1"/>
<clue>Interferons <clueType>induce</clueType> normal and aberrant retinoic-acid receptors type alpha <clueLoc>in acute promyelocytic leukemia cells</clueLoc>: potentiation of the induction of retinoid-dependent differentiation markers.</clue>
<comment>NER T4,T6 MOD</comment></event>
<event KT="Other" id="E2">
<type class="Positive_regulation"/>
<theme idref="T6"/>
<cause idref="T5"/>
<clue>Interferons induce normal and aberrant retinoic-acid receptors type alpha in acute promyelocytic leukemia cells: potentiation of the induction of retinoid-<clueType>dependent</clueType> differentiation markers.</clue>
</event>
<event KT="Other" id="E3">
<type class="Positive_regulation"/>
<theme idref="T4"/>
<clue>Interferons induce normal and aberrant retinoic-acid receptors type alpha in acute promyelocytic leukemia cells: potentiation of the <clueType>induction</clueType> <linkTheme>of</linkTheme> retinoid-dependent differentiation markers.</clue>
</event>
<event KT="Investigation" id="E4">
<type class="Positive_regulation"/>
<theme idref="E3"/>
<cause idref="T1"/>
<clue>Interferons induce normal and aberrant retinoic-acid receptors type alpha in acute promyelocytic leukemia cells: <clueType>potentiation</clueType> <linkTheme>of</linkTheme> the induction of retinoid-dependent differentiation markers.</clue>
<comment>NO COREFCAUSE</comment></event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">Treatment of the <term id="T7" lex="acute_promyelocytic_(APL)_cell_line" sem="Cell_cultured">acute promyelocytic (APL) cell line</term> <term id="T8" lex="NB4" sem="Cell_cultured">NB4</term> with <term id="T9" lex="interferon_alpha" sem="Protein_molecule">interferon alpha</term> (<term id="T10" lex="IFN(alpha)" sem="Protein_molecule">IFN(alpha)</term>), as well as <cons id="T11" lex="(AND IFN(beta) IFN_gamma)" sem="(AND Protein_molecule Protein_molecule)"><frag id="F1">IFN</frag>(<frag id="F2">beta</frag>) and <frag id="F3">gamma</frag></cons>, results in an increased expression of the <term id="A5" sem="RNA_molecule">transcripts coding for</term> <term id="T12" lex="retinoic-acid_receptor_type_alpha" sem="Protein_molecule">retinoic-acid receptor type alpha</term> (<term id="A6" sem="RNA_molecule"><term id="T13" lex="RAR(alpha)" sem="Protein_molecule">RAR(alpha)</term></term>) and the <term id="T14" lex="leukemia-specific_retinoic_acid_receptor" sem="Protein_family_or_group">leukemia-specific retinoic acid receptor</term> <term id="A7" sem="RNA_molecule"><term id="T15" lex="PML-RAR" sem="Protein_molecule">PML-RAR</term></term>.</sentence>
<event id="E5">
<type class="Transcription"/>
<theme idref="A5" idref1="A6"/>
<clue>Treatment of the acute promyelocytic (APL) cell line NB4 with interferon alpha (IFN(alpha)), as well as IFN(beta) and gamma, results in an increased <clueType>expression</clueType> <linkTheme>of</linkTheme> the transcripts coding for retinoic-acid receptor type alpha (RAR(alpha)) and the leukemia-specific retinoic acid receptor PML-RAR.</clue>
<comment>TPS A5</comment></event>
<event id="E6">
<type class="Transcription"/>
<theme idref="A5" idref1="A7"/>
<clue>Treatment of the acute promyelocytic (APL) cell line NB4 with interferon alpha (IFN(alpha)), as well as IFN(beta) and gamma, results in an increased <clueType>expression</clueType> <linkTheme>of</linkTheme> the transcripts coding for retinoic-acid receptor type alpha (RAR(alpha)) and the leukemia-specific retinoic acid receptor PML-RAR.</clue>
</event>
<event id="E7">
<type class="Positive_regulation"/>
<theme idref="E5"/>
<cause idref="T10"/>
<clue><linkCause>Treatment</linkCause> of <clueLoc>the acute promyelocytic (APL) cell line NB4</clueLoc> <linkCause>with</linkCause> interferon alpha (IFN(alpha)), as well as IFN(beta) and gamma, <clueType>results in an increased</clueType> expression of the transcripts coding for retinoic-acid receptor type alpha (RAR(alpha)) and the leukemia-specific retinoic acid receptor PML-RAR.</clue>
</event>
<event id="E8">
<type class="Positive_regulation"/>
<theme idref="E6"/>
<cause idref="T10"/>
<clue><linkCause>Treatment</linkCause> of <clueLoc>the acute promyelocytic (APL) cell line NB4</clueLoc> <linkCause>with</linkCause> interferon alpha (IFN(alpha)), as well as IFN(beta) and gamma, <clueType>results in an increased</clueType> expression of the transcripts coding for retinoic-acid receptor type alpha (RAR(alpha)) and the leukemia-specific retinoic acid receptor PML-RAR.</clue>
</event>
<event id="E9">
<type class="Positive_regulation"/>
<theme idref="E5"/>
<cause idref="F1" idref1="F2"/>
<clue><linkCause>Treatment</linkCause> of <clueLoc>the acute promyelocytic (APL) cell line NB4</clueLoc> with interferon alpha (IFN(alpha)), <linkCause>as well as</linkCause> IFN(beta) and gamma, <clueType>results in an increased</clueType> expression of the transcripts coding for retinoic-acid receptor type alpha (RAR(alpha)) and the leukemia-specific retinoic acid receptor PML-RAR.</clue>
</event>
<event id="E10">
<type class="Positive_regulation"/>
<theme idref="E6"/>
<cause idref="F1" idref1="F2"/>
<clue><linkCause>Treatment</linkCause> of <clueLoc>the acute promyelocytic (APL) cell line NB4</clueLoc> with interferon alpha (IFN(alpha)), <linkCause>as well as</linkCause> IFN(beta) and gamma, <clueType>results in an increased</clueType> expression of the transcripts coding for retinoic-acid receptor type alpha (RAR(alpha)) and the leukemia-specific retinoic acid receptor PML-RAR.</clue>
</event>
<event id="E11">
<type class="Positive_regulation"/>
<theme idref="E5"/>
<cause idref="F1" idref1="F3"/>
<clue><linkCause>Treatment</linkCause> of <clueLoc>the acute promyelocytic (APL) cell line NB4</clueLoc> with interferon alpha (IFN(alpha)), <linkCause>as well as</linkCause> IFN(beta) and gamma, <clueType>results in an increased</clueType> expression of the transcripts coding for retinoic-acid receptor type alpha (RAR(alpha)) and the leukemia-specific retinoic acid receptor PML-RAR.</clue>
</event>
<event id="E12">
<type class="Positive_regulation"/>
<theme idref="E6"/>
<cause idref="F1" idref1="F3"/>
<clue><linkCause>Treatment</linkCause> of <clueLoc>the acute promyelocytic (APL) cell line NB4</clueLoc> with interferon alpha (IFN(alpha)), <linkCause>as well as</linkCause> IFN(beta) and gamma, <clueType>results in an increased</clueType> expression of the transcripts coding for retinoic-acid receptor type alpha (RAR(alpha)) and the leukemia-specific retinoic acid receptor PML-RAR.</clue>
</event>
<sentence id="S3">Transcriptional induction of the <cons id="T16" lex="(AND RAR(alpha)_mRNA PML-RAR_mRNA)" sem="(AND RNA_molecule RNA_molecule)"><frag id="F4"><term id="A11" sem="Protein_molecule">RAR(alpha)</term></frag> and <frag id="F5"><term id="A12" sem="Protein_molecule">PML-RAR</term></frag> <frag id="F6">mRNAs</frag></cons> is rapid and it is parallelled by an increase in the corresponding proteins.</sentence>
<event Manner="High" id="E13">
<type class="Positive_regulation"/>
<theme idref="F4" idref1="F6"/>
<cause idref="T10"/>
<clue><clueType>Transcriptional induction</clueType> <linkTheme>of</linkTheme> the RAR(alpha) and PML-RAR mRNAs is <clueManner>rapid</clueManner> and it is parallelled by an increase in the corresponding proteins.</clue>
<comment>NO COREFCAUSE</comment></event>
<event Manner="High" id="E113">
<type class="Positive_regulation"/>
<theme idref="F4" idref1="F6"/>
<cause idref="F1" idref1="F2"/>
<clue><clueType>Transcriptional induction</clueType> <linkTheme>of</linkTheme> the RAR(alpha) and PML-RAR mRNAs is <clueManner>rapid</clueManner> and it is parallelled by an increase in the corresponding proteins.</clue>
<comment>NO COREFCAUSE</comment></event>
<event Manner="High" id="E114">
<type class="Positive_regulation"/>
<theme idref="F4" idref1="F6"/>
<cause idref="F1" idref1="F3"/>
<clue><clueType>Transcriptional induction</clueType> <linkTheme>of</linkTheme> the RAR(alpha) and PML-RAR mRNAs is <clueManner>rapid</clueManner> and it is parallelled by an increase in the corresponding proteins.</clue>
<comment>NO COREFCAUSE</comment></event>
<event Manner="High" id="E14">
<type class="Positive_regulation"/>
<theme idref="F5" idref1="F6"/>
<clue><clueType>Transcriptional induction</clueType> <linkTheme>of</linkTheme> the RAR(alpha) and PML-RAR mRNAs is <clueManner>rapid</clueManner> and it is parallelled by an increase in the corresponding proteins.</clue>
<comment>NO COREFCAUSE</comment></event>
<event Manner="High" id="E115">
<type class="Positive_regulation"/>
<theme idref="F5" idref1="F6"/>
<cause idref="F1" idref1="F2"/>
<clue><clueType>Transcriptional induction</clueType> <linkTheme>of</linkTheme> the RAR(alpha) and PML-RAR mRNAs is <clueManner>rapid</clueManner> and it is parallelled by an increase in the corresponding proteins.</clue>
<comment>NO COREFCAUSE</comment></event>
<event Manner="High" id="E116">
<type class="Positive_regulation"/>
<theme idref="F5" idref1="F6"/>
<cause idref="F1" idref1="F3"/>
<clue><clueType>Transcriptional induction</clueType> <linkTheme>of</linkTheme> the RAR(alpha) and PML-RAR mRNAs is <clueManner>rapid</clueManner> and it is parallelled by an increase in the corresponding proteins.</clue>
<comment>NO COREFCAUSE</comment></event>
<event Manner="High" id="E15">
<type class="Positive_regulation"/>
<theme idref="A11"/>
<clue>Transcriptional induction of the RAR(alpha) and PML-RAR mRNAs is <clueManner>rapid</clueManner> and it is parallelled by an <clueType>increase</clueType> <linkTheme>in</linkTheme> <corefTheme>the corresponding proteins</corefTheme>.</clue>
</event>
<event Manner="High" id="E16">
<type class="Positive_regulation"/>
<theme idref="A12"/>
<clue>Transcriptional induction of the RAR(alpha) and PML-RAR mRNAs is <clueManner>rapid</clueManner> and it is parallelled by an <clueType>increase</clueType> <linkTheme>in</linkTheme> <corefTheme>the corresponding proteins</corefTheme>.</clue>
</event>
<event id="E17">
<type class="Positive_regulation"/>
<theme idref="E15"/>
<cause idref="E13"/>
<clue>Transcriptional induction of the RAR(alpha) and PML-RAR mRNAs is rapid and it is <clueType>parallelled</clueType> <linkTheme>by</linkTheme> an increase in the corresponding proteins.</clue>
</event>
<event id="E18">
<type class="Positive_regulation"/>
<theme idref="E16"/>
<cause idref="E14"/>
<clue>Transcriptional induction of the RAR(alpha) and PML-RAR mRNAs is rapid and it is <clueType>parallelled</clueType> <linkTheme>by</linkTheme> an increase in the corresponding proteins.</clue>
</event>
<sentence id="S4">Up-regulation of <cons id="C2" lex="(AND RAR(alpha)_gene_expression PML-RAR_gene_expression)" sem="(AND Other Other)"><cons id="C1" lex="(AND RAR(alpha)_gene PML-RAR_gene)" sem="(AND DNA_domain_or_region DNA_domain_or_region)"><frag id="F7">RAR(alpha)</frag> and <frag id="F8">PML-RAR</frag> <frag id="F9">gene</frag></cons> <frag id="F10">expression</frag></cons> by <term id="T20" lex="IFN(alpha)" sem="Protein_molecule">IFN(alpha)</term> is accompanied by a strong potentiation in the induction of 2 <term id="T21" lex="retinoid-dependent_granulocytic_marker" sem="Protein_family_or_group"><term id="T22" lex="retinoid" sem="Organic_compound_other">retinoid</term>-dependent <term id="A14" sem="Protein_family_or_group">granulocytic markers</term></term>, i.e., <term id="T23" lex="granulocyte-colony-stimulating_factor_receptor_mRNA" sem="RNA_molecule"><term id="T24" lex="granulocyte-colony-stimulating_factor_receptor" sem="Protein_family_or_group">granulocyte-colony-stimulating factor receptor</term> mRNA</term> and <term id="T25" lex="leukocyte_alkaline_phosphatase" sem="Protein_molecule">leukocyte alkaline phosphatase</term>.</sentence>
<event id="E19">
<type class="Gene_expression"/>
<theme idref="F7" idref1="F9"/>
<clue>Up-regulation of RAR(alpha) and PML-RAR gene <clueType>expression</clueType> by IFN(alpha) is accompanied by a strong potentiation in the induction of 2 retinoid-dependent granulocytic markers, i.e., granulocyte-colony-stimulating factor receptor mRNA and leukocyte alkaline phosphatase.</clue>
<comment>NER T17,T18,T21 MOD</comment></event>
<event id="E20">
<type class="Gene_expression"/>
<theme idref="F8" idref1="F9"/>
<clue>Up-regulation of RAR(alpha) and PML-RAR gene <clueType>expression</clueType> by IFN(alpha) is accompanied by a strong potentiation in the induction of 2 retinoid-dependent granulocytic markers, i.e., granulocyte-colony-stimulating factor receptor mRNA and leukocyte alkaline phosphatase.</clue>
</event>
<event id="E21">
<type class="Positive_regulation"/>
<theme idref="E19"/>
<cause idref="T20"/>
<clue><clueType>Up-regulation</clueType> <linkTheme>of</linkTheme> RAR(alpha) and PML-RAR gene expression <linkCause>by</linkCause> IFN(alpha) is accompanied by a strong potentiation in the induction of 2 retinoid-dependent granulocytic markers, i.e., granulocyte-colony-stimulating factor receptor mRNA and leukocyte alkaline phosphatase.</clue>
</event>
<event id="E22">
<type class="Positive_regulation"/>
<theme idref="E20"/>
<cause idref="T20"/>
<clue><clueType>Up-regulation</clueType> <linkTheme>of</linkTheme> RAR(alpha) and PML-RAR gene expression by IFN(alpha) is accompanied by a strong potentiation in the induction of 2 retinoid-dependent granulocytic markers, i.e., granulocyte-colony-stimulating factor receptor mRNA and leukocyte alkaline phosphatase.</clue>
</event>
<event Manner="High" id="E23">
<type class="Positive_regulation"/>
<theme idref="T21"/>
<clue>Up-regulation of RAR(alpha) and PML-RAR gene expression by IFN(alpha) is accompanied by a <clueManner>strong</clueManner> potentiation in the <clueType>induction</clueType> <linkCause>of</linkCause> 2 retinoid-dependent granulocytic markers, i.e., granulocyte-colony-stimulating factor receptor mRNA and leukocyte alkaline phosphatase.</clue>
</event>
<event Manner="High" id="E24">
<type class="Positive_regulation"/>
<theme idref="T23"/>
<clue>Up-regulation of RAR(alpha) and PML-RAR gene expression by IFN(alpha) is accompanied by a <clueManner>strong</clueManner> potentiation in the <clueType>induction</clueType> <linkCause>of</linkCause> 2 retinoid-dependent granulocytic markers, i.e., granulocyte-colony-stimulating factor receptor mRNA and leukocyte alkaline phosphatase.</clue>
</event>
<event Manner="High" id="E25">
<type class="Positive_regulation"/>
<theme idref="T25"/>
<clue>Up-regulation of RAR(alpha) and PML-RAR gene expression by IFN(alpha) is accompanied by a <clueManner>strong</clueManner> potentiation in the <clueType>induction</clueType> <linkCause>of</linkCause> 2 retinoid-dependent granulocytic markers, i.e., granulocyte-colony-stimulating factor receptor mRNA and leukocyte alkaline phosphatase.</clue>
</event>
<event id="E26">
<type class="Correlation"/>
<theme idref="E21"/>
<theme idref="E23"/>
<clue>Up-regulation of RAR(alpha) and PML-RAR gene expression by IFN(alpha) is <clueType>accompanied</clueType> <linkTheme>by</linkTheme> a strong potentiation in the induction of 2 retinoid-dependent granulocytic markers, i.e., granulocyte-colony-stimulating factor receptor mRNA and leukocyte alkaline phosphatase.</clue>
</event>
<event id="E27">
<type class="Correlation"/>
<theme idref="E21"/>
<theme idref="E24"/>
<clue>Up-regulation of RAR(alpha) and PML-RAR gene expression by IFN(alpha) is <clueType>accompanied</clueType> <linkTheme>by</linkTheme> a strong potentiation in the induction of 2 retinoid-dependent granulocytic markers, i.e., granulocyte-colony-stimulating factor receptor mRNA and leukocyte alkaline phosphatase.</clue>
</event>
<event id="E28">
<type class="Correlation"/>
<theme idref="E21"/>
<theme idref="E25"/>
<clue>Up-regulation of RAR(alpha) and PML-RAR gene expression by IFN(alpha) is <clueType>accompanied</clueType> <linkTheme>by</linkTheme> a strong potentiation in the induction of 2 retinoid-dependent granulocytic markers, i.e., granulocyte-colony-stimulating factor receptor mRNA and leukocyte alkaline phosphatase.</clue>
</event>
<event id="E29">
<type class="Correlation"/>
<theme idref="E22"/>
<theme idref="E23"/>
<clue>Up-regulation of RAR(alpha) and PML-RAR gene expression by IFN(alpha) is <clueType>accompanied</clueType> <linkTheme>by</linkTheme> a strong potentiation in the induction of 2 retinoid-dependent granulocytic markers, i.e., granulocyte-colony-stimulating factor receptor mRNA and leukocyte alkaline phosphatase.</clue>
</event>
<event id="E30">
<type class="Correlation"/>
<theme idref="E22"/>
<theme idref="E24"/>
<clue>Up-regulation of RAR(alpha) and PML-RAR gene expression by IFN(alpha) is <clueType>accompanied</clueType> <linkTheme>by</linkTheme> a strong potentiation in the induction of 2 retinoid-dependent granulocytic markers, i.e., granulocyte-colony-stimulating factor receptor mRNA and leukocyte alkaline phosphatase.</clue>
</event>
<event id="E31">
<type class="Correlation"/>
<theme idref="E22"/>
<theme idref="E25"/>
<clue>Up-regulation of RAR(alpha) and PML-RAR gene expression by IFN(alpha) is <clueType>accompanied</clueType> <linkTheme>by</linkTheme> a strong potentiation in the induction of 2 retinoid-dependent granulocytic markers, i.e., granulocyte-colony-stimulating factor receptor mRNA and leukocyte alkaline phosphatase.</clue>
</event>
<event id="E47">
<type class="Positive_regulation"/>
<theme idref="A14"/>
<cause idref="T22"/>
<clue>Up-regulation of RAR(alpha) and PML-RAR gene expression by IFN(alpha) is accompanied by a strong potentiation in the induction of 2 retinoid-<clueType>dependent</clueType> granulocytic markers, i.e., granulocyte-colony-stimulating factor receptor mRNA and leukocyte alkaline phosphatase.</clue>
</event>
<sentence id="S5">However, <term id="T26" lex="IFN(alpha)" sem="Protein_molecule">IFN(alpha)</term> does not have any effects on the <term id="T27" lex="retinoid-dependent_regulation" sem="Other"><term id="T28" lex="retinoid" sem="Organic_compound_other">retinoid</term>-dependent regulation</term> of the <term id="T29" lex="myeloid_surface_marker" sem="Protein_family_or_group">myeloid surface markers</term> <term id="T30" lex="CD11b" sem="Protein_molecule">CD11b</term> and <term id="T31" lex="CD33" sem="Protein_molecule">CD33</term>.</sentence>
<event id="E32">
<type class="Regulation"/>
<theme idref="T30"/>
<cause idref="T28"/>
<clue>However, IFN(alpha) does not have any effects on the retinoid-<linkCause>dependent</linkCause> <clueType>regulation</clueType> <linkTheme>of</linkTheme> the myeloid surface markers CD11b and CD33.</clue>
</event>
<event id="E33">
<type class="Regulation"/>
<theme idref="T31"/>
<cause idref="T28"/>
<clue>However, IFN(alpha) does not have any effects on the retinoid-<linkCause>dependent</linkCause> <clueType>regulation</clueType> <linkTheme>of</linkTheme> the myeloid surface markers CD11b and CD33.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E34">
<type class="Regulation"/>
<theme idref="E32"/>
<cause idref="T26"/>
<clue>However, IFN(alpha) does <cluePolarity>not</cluePolarity> <clueType>have</clueType> any <clueType>effects</clueType> <linkTheme>on</linkTheme> the retinoid-dependent regulation of the myeloid surface markers CD11b and CD33.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E35">
<type class="Regulation"/>
<theme idref="E33"/>
<cause idref="T26"/>
<clue>However, IFN(alpha) does <cluePolarity>not</cluePolarity> <clueType>have</clueType> any <clueType>effects</clueType> <linkTheme>on</linkTheme> the retinoid-dependent regulation of the myeloid surface markers CD11b and CD33.</clue>
</event>
<sentence id="S6">The <term id="T32" lex="IFN-dependent_increase" sem="Other"><term id="T33" lex="IFN" sem="Protein_family_or_group">IFN</term>-dependent increase</term> in <term id="T34" lex="RAR(alpha)_level" sem="Other"><term id="T35" lex="RAR(alpha)" sem="Protein_molecule">RAR(alpha)</term> levels</term> and the enhancing effect of the <term id="T36" lex="cytokine" sem="Protein_family_or_group">cytokine</term> on <term id="T37" lex="retinoid-dependent_granulocytic_markers_expression" sem="Other"><term id="T38" lex="retinoid-dependent_granulocytic_marker" sem="Protein_family_or_group"><term id="T39" lex="retinoid" sem="Organic_compound_other">retinoid</term>-dependent <term id="A15" sem="Protein_family_or_group">granulocytic markers</term></term> expression</term> may be a characteristic of <term id="T40" lex="PML-RAR_positive_cell" sem="Cell_cultured"><term id="T41" lex="PML-RAR" sem="Protein_molecule">PML-RAR</term> positive cells</term>, since the phenomena are not observed in <term id="T42" lex="HL-60_promyelocyte" sem="Cell_cultured">HL-60 promyelocytes</term>.</sentence>
<event KT="Other" id="E36">
<type class="Positive_regulation"/>
<theme idref="T35"/>
<cause idref="T33"/>
<clue>The IFN-<linkCause>dependent</linkCause> <clueType>increase</clueType> <linkTheme>in</linkTheme> RAR(alpha) levels and the enhancing effect of the cytokine on retinoid-dependent granulocytic markers expression may be a characteristic of <clueLoc>PML-RAR positive cells</clueLoc>, since the phenomena are not observed in HL-60 promyelocytes.</clue>
</event>
<event KT="Other" id="E37">
<type class="Positive_regulation"/>
<theme idref="E38"/>
<cause idref="T39"/>
<clue>The IFN-dependent increase in RAR(alpha) levels and the enhancing effect of the cytokine on retinoid-<clueType>dependent</clueType> granulocytic markers expression may be a characteristic of PML-RAR positive cells, since the phenomena are not observed in HL-60 promyelocytes.</clue>
</event>
<event KT="Other" id="E38">
<type class="Gene_expression"/>
<theme idref="T38"/>
<clue>The IFN-dependent increase in RAR(alpha) levels and the enhancing effect of the cytokine on retinoid-dependent granulocytic markers <clueType>expression</clueType> may be a characteristic of PML-RAR positive cells, since the phenomena are not observed in HL-60 promyelocytes.</clue>
</event>
<event CL="L1" KT="Analysis" id="E39">
<type class="Positive_regulation"/>
<theme idref="E37"/>
<cause idref="T36"/>
<clue>The IFN-dependent increase in RAR(alpha) levels and the <clueType>enhancing effect</clueType> <linkCause>of</linkCause> the cytokine <linkTheme>on</linkTheme> retinoid-dependent granulocytic markers expression <clueKT><clueCL>may</clueCL></clueKT> be a characteristic of <clueLoc>PML-RAR positive cells</clueLoc>, since the phenomena are not observed in HL-60 promyelocytes.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E40">
<type class="Positive_regulation"/>
<theme idref="T35"/>
<cause idref="T33"/>
<clue>The IFN-dependent increase in RAR(alpha) levels and the enhancing effect of the cytokine on retinoid-dependent granulocytic markers expression may be a characteristic of PML-RAR positive cells, since the phenomena are <cluePolarity>not</cluePolarity> <clueType><clueKT>observed</clueKT></clueType> <clueLoc>in HL-60 promyelocytes</clueLoc>.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E41">
<type class="Positive_regulation"/>
<theme idref="E37"/>
<cause idref="T36"/>
<clue>The IFN-dependent increase in RAR(alpha) levels and the enhancing effect of the cytokine on retinoid-dependent granulocytic markers expression may be a characteristic of PML-RAR positive cells, since the phenomena are <cluePolarity>not</cluePolarity> <clueType><clueKT>observed</clueKT></clueType> <clueLoc>in HL-60 promyelocytes</clueLoc>.</clue>
</event>
<sentence id="S7"><term id="T43" lex="interferon" sem="Protein_family_or_group">Interferons</term> as well as <term id="T44" lex="retinoid" sem="Organic_compound_other">retinoids</term> inhibit the growth of <term id="T45" lex="NB4_cell" sem="Cell_cultured">NB4 cells</term>, although the 2 classes of compounds do not significantly interact in terms of <term id="T46" lex="anti-proliferative_activity" sem="Other">anti-<term id="A16" sem="Other">proliferative</term> activity</term>.</sentence>
<event KT="Other" id="E42">
<type class="Cellular_process"/>
<theme idref="T45"/>
<clue>Interferons as well as retinoids inhibit the <clueType>growth</clueType> <linkTheme>of</linkTheme> NB4 cells, although the 2 classes of compounds do not significantly interact in terms of anti-proliferative activity.</clue>
</event>
<event id="E43">
<type class="Negative_regulation"/>
<theme idref="E42"/>
<cause idref="T43"/>
<clue>Interferons as well as retinoids <clueType>inhibit</clueType> the growth of NB4 cells, although the 2 classes of compounds do not significantly interact in terms of anti-proliferative activity.</clue>
</event>
<event id="E44">
<type class="Negative_regulation"/>
<theme idref="E42"/>
<cause idref="T44"/>
<clue>Interferons as well as retinoids <clueType>inhibit</clueType> the growth of NB4 cells, although the 2 classes of compounds do not significantly interact in terms of anti-proliferative activity.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E45">
<type class="Positive_regulation"/>
<theme idref="E46"/>
<cause idref="T43"/>
<cause idref="T44"/>
<clue>Interferons as well as retinoids inhibit the growth of NB4 cells, although <corefTheme>the 2 classes of compounds</corefTheme> do <cluePolarity>not</cluePolarity> significantly <clueType>interact</clueType> <linkTheme>in terms of</linkTheme> anti-proliferative activity.</clue>
</event>
<event KT="Other" id="E46">
<type class="Negative_regulation"/>
<theme idref="A16"/>
<clue>Interferons as well as retinoids inhibit the growth of NB4 cells, although the 2 classes of compounds do not significantly interact in terms of <clueType>anti</clueType>-proliferative <clueType>activity</clueType>.</clue>
</event>
<sentence id="S8">These results suggest the possible use of combinations between <term id="T47" lex="IFN" sem="Protein_family_or_group">IFNs</term> and <term id="T48" lex="retinoic_acid" sem="Organic_compound_other">retinoic acid</term> in the <term id="T49" lex="cyto-differentiating_treatment" sem="Other">cyto-differentiating treatment</term> of <term id="T50" lex="APL_patient" sem="Multicellular_organism_natural">APL patients</term>.</sentence>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
